Literature DB >> 20534368

Rational treatment of fibromyalgia for a solo practitioner.

Eduardo S Paiva1, Kim Dupree Jones.   

Abstract

Fibromyalgia (FM) is a challenging condition, but the management of patients with FM is becoming facilitated by new medications that act in what are thought to be some of most important pathophysiological features in this syndrome. However, it is of pivotal importance that an interdisciplinary approach is used to improve pain, fatigue, sleep and other domains to improve quality of life. Here, we present elements of management that the solo practitioner can tackle, focussing in the formally approved drugs for FM and other drugs commonly used in this condition. Further, the elements of an ideal multidisciplinary team are presented, and on how to incorporate their recommendations for the treatment of FM. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20534368     DOI: 10.1016/j.berh.2009.12.010

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  4 in total

Review 1.  A framework for fibromyalgia management for primary care providers.

Authors:  Lesley M Arnold; Daniel J Clauw; L Jean Dunegan; Dennis C Turk
Journal:  Mayo Clin Proc       Date:  2012-05       Impact factor: 7.616

2.  A randomized controlled trial of 8-form Tai chi improves symptoms and functional mobility in fibromyalgia patients.

Authors:  Kim D Jones; Christy A Sherman; Scott D Mist; James W Carson; Robert M Bennett; Fuzhong Li
Journal:  Clin Rheumatol       Date:  2012-05-13       Impact factor: 2.980

3.  Living with a double burden: Meanings of pain for women with fibromyalgia.

Authors:  Päivi Juuso; Lisa Skär; Malin Olsson; Siv Söderberg
Journal:  Int J Qual Stud Health Well-being       Date:  2011-07-13

4.  Nordic walking in fibromyalgia: a means of promoting fitness that is easy for busy clinicians to recommend.

Authors:  Kim Dupree Jones
Journal:  Arthritis Res Ther       Date:  2011-02-16       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.